Literature DB >> 7826113

Analysis of cells obtained by bronchial lavage of infants with respiratory syncytial virus infection.

M L Everard1, A Swarbrick, M Wrightham, J McIntyre, C Dunkley, P D James, H F Sewell, A D Milner.   

Abstract

To study the cellular infiltrate that occurs within the airways of infants with respiratory syncytial virus bronchiolitis, samples of airways secretions were obtained by bronchial lavage from the lower respiratory tract of infants ventilated for this condition and from the upper airway of non-intubated infants with this disorder using nasopharyngeal aspirates. Cytospin samples were prepared so that differential cell counts could be performed on the cells obtained and alkaline phosphatase-antialkaline phosphatase immunocytochemical analysis of lymphocyte subsets was carried out using a panel of monoclonal antibodies, which included anti-CD3, anti-CD4, anti-CD8, anti-CD19, and anti-TcR gamma delta. Results from the lower and upper airways were similar. Large numbers of inflammatory cells were obtained, of which neutrophils accounted for a median of 93% in the upper airway and 76% in the lower airway. The numbers of CD8 positive cells detected were small and consistently less than CD4 positive cells, median CD4:CD8 ratios being 22.5:1 and 15:1 for the lower and upper airways. CD19 positive cells were rarely observed and no gamma delta positive lymphocytes were detected. These results indicate that neutrophils probably play a major part in causing symptoms in these infants. They do not support the concept that excessive lymphocyte mediated cytotoxic activity is principally responsible for the pathology in respiratory syncytial virus bronchiolitis.

Entities:  

Mesh:

Year:  1994        PMID: 7826113      PMCID: PMC1030058          DOI: 10.1136/adc.71.5.428

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  32 in total

1.  A controlled study of oxygen metabolite release by alveolar macrophages from children with interstitial lung disease.

Authors:  A Clement; K Chadelat; J Masliah; B Housset; A Sardet; A Grimfeld; G Tournier
Journal:  Am Rev Respir Dis       Date:  1987-12

Review 2.  Macrophages and polymorphonuclear neutrophils in lung defense and injury.

Authors:  Y Sibille; H Y Reynolds
Journal:  Am Rev Respir Dis       Date:  1990-02

Review 3.  The role of neutrophils in the pathogenesis of rhinovirus infections.

Authors:  R B Turner
Journal:  Pediatr Infect Dis J       Date:  1990-11       Impact factor: 2.129

Review 4.  Neutrophil attractant/activation protein-1 (NAP-1 [interleukin-8]).

Authors:  E J Leonard; T Yoshimura
Journal:  Am J Respir Cell Mol Biol       Date:  1990-06       Impact factor: 6.914

5.  Cell-mediated cytotoxic response to respiratory syncytial virus in infants with bronchiolitis.

Authors:  D Isaacs; C R Bangham; A J McMichael
Journal:  Lancet       Date:  1987-10-03       Impact factor: 79.321

6.  Fatal respiratory syncytial virus infection in severe combined immunodeficiency syndrome.

Authors:  M E Milner; S M de la Monte; G M Hutchins
Journal:  Am J Dis Child       Date:  1985-11

7.  The development of respiratory syncytial virus-specific immune complexes in nasopharyngeal secretions following natural infection.

Authors:  T N Kaul; R C Welliver; H S Faden; P L Ogra
Journal:  J Clin Lab Immunol       Date:  1984-12

8.  Complement activation by respiratory syncytial virus-infected cells.

Authors:  K M Edwards; P N Snyder; P F Wright
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

9.  Duration of hospitalization in previously well infants with respiratory syncytial virus infection.

Authors:  M Green; A F Brayer; K A Schenkman; E R Wald
Journal:  Pediatr Infect Dis J       Date:  1989-09       Impact factor: 2.129

10.  Cytotoxic T cells clear virus but augment lung pathology in mice infected with respiratory syncytial virus.

Authors:  M J Cannon; P J Openshaw; B A Askonas
Journal:  J Exp Med       Date:  1988-09-01       Impact factor: 14.307

View more
  124 in total

1.  Immunological responses to respiratory syncytial virus infection in infancy.

Authors:  R L Smyth; J N Fletcher; H M Thomas; C A Hart
Journal:  Arch Dis Child       Date:  1997-03       Impact factor: 3.791

2.  Respiratory syncytial virus infection in human bone marrow stromal cells.

Authors:  Fariba Rezaee; Laura F Gibson; Debbie Piktel; Sreekumar Othumpangat; Giovanni Piedimonte
Journal:  Am J Respir Cell Mol Biol       Date:  2010-10-22       Impact factor: 6.914

3.  Respiratory syncytial virus-inducible BCL-3 expression antagonizes the STAT/IRF and NF-kappaB signaling pathways by inducing histone deacetylase 1 recruitment to the interleukin-8 promoter.

Authors:  Mohammad Jamaluddin; Sanjeev Choudhary; Shaofei Wang; Antonella Casola; Ruksana Huda; Roberto P Garofalo; Sutapa Ray; Allan R Brasier
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

4.  Autocrine regulation of interleukin-8 by interleukin-1alpha in respiratory syncytial virus-infected pulmonary epithelial cells in vitro.

Authors:  J A Patel; Z Jiang; N Nakajima; M Kunimoto
Journal:  Immunology       Date:  1998-12       Impact factor: 7.397

Review 5.  Respiratory viral infections in hematopoietic stem cell and solid organ transplant recipients.

Authors:  S Samuel Weigt; Aric L Gregson; Jane C Deng; Joseph P Lynch; John A Belperio
Journal:  Semin Respir Crit Care Med       Date:  2011-08-19       Impact factor: 3.119

Review 6.  Animal pneumoviruses: molecular genetics and pathogenesis.

Authors:  Andrew J Easton; Joseph B Domachowske; Helene F Rosenberg
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

Review 7.  The immune response to respiratory syncytial virus infection: friend or foe?

Authors:  Robert C Welliver
Journal:  Clin Rev Allergy Immunol       Date:  2008-04       Impact factor: 8.667

Review 8.  Bronchiolitis. Origins and optimal management.

Authors:  M L Everard
Journal:  Drugs       Date:  1995-06       Impact factor: 9.546

9.  A systemic neutrophil response precedes robust CD8(+) T-cell activation during natural respiratory syncytial virus infection in infants.

Authors:  Michaël V Lukens; Alma C van de Pol; Frank E J Coenjaerts; Nicolaas J G Jansen; Vera M Kamp; Jan L L Kimpen; John W A Rossen; Laurien H Ulfman; Carline E A Tacke; Marco C Viveen; Leo Koenderman; Tom F W Wolfs; Grada M van Bleek
Journal:  J Virol       Date:  2009-12-16       Impact factor: 5.103

Review 10.  Human genetic factors and respiratory syncytial virus disease severity.

Authors:  Isao Miyairi; John P DeVincenzo
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.